Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | L-Serine | HCID 5951 | — |
| Reactant | Isooctanoic acid | HCID 90716 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | Acetoacetic Acid | HCID 96 | — |
| Product | Acetic Anhydride | HCID 7918 | — |
Reaction Steps
BU-3862T exhibits strong absorptions at 3300 (hydroxy), 1720 (carbonyl), 1650 and 1530 cm-1 (amide) in the IR spectrum indicating a peptide structure for the antibiotic. The 13C-NMR spectrum demonstrated 20 carbons which were identified as two C-CH3, one=C-CH3, eight -CH2, three -CH, one>C<, one>C=CH2 and three C=O carbons. The molecular formula of BU-3862T was established as C20H34N2O6 based on the microanalysis, mass spectral data((M+H)+ : m/z 399) and 13C-NMR spectral analysis. Thirty-four protons were observed in the 1H-NMR spectrum. The two doublet protons (δ7.03 and 6.48 ppm, in CDCl3) gradually disappeared by the addition of deutrium oxide were assigned to two -NH-CO groups. The broad two singlet protons (δ4.83 and 4.79) and the AB type doublet protons (δ3.35 and 3.12, J:5.0 Hz) were assigned to exomethylene(-(CH3)C=CH2 ) and epoxide ##STR6## protons, respectively. The connectivities of these protons were determined by 1H-1H COSY experiments leading to the partial structures as shown below. Further connectivities of the partial structures were established by the 13C-1H COSY and 13C-1H long range COSY experiments. They were analyzed as shown below and thus the total structure of BU-3862T was determined. Further evidence for the structure was provided by its mass spectrum and degradation experiment. The EI-MS spectrum exhibited abundant fragment ions at m/z 127 (iso-octanoyl), 214 (iso-octanoyl-seryl) and 325 (iso-octanoyl-seryl-4,5-didehydroleucyl) supporting the structure. Upon acid hydrolysis, BU-3862T gave an amino acid and a fatty acid. The amino acid isolated was identified as L-serine by HPLC and the fatty acid as iso-octanoic acid by gas chromatography of its methyl ester. BU-3862T afforded the diacetate derivative upon treatment with acetic anhydride in pyridine. When hydrogenated over palladium carbon, BU-3862T afforded two reduction products, dihydro-BU-3862T and tetrahydro-BU-3862T, whose structures were determined based on their spectral data. The diacetate and the dihydro compound retained the biological activity but the tetrahydro derivative was devoid of the activity.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04912133 |
|---|
| Source dataset | uspto-grants-1990_03 |
|---|
| ORD ID | ord-1f70f43976974080b4baea9827a29b01 |
|---|
| Source note | uspto-grants-1990_03 |
|---|